Steven Stone
Overview
Explore the profile of Steven Stone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1772
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Assil T, Handelsman S, Ansari F, Flatley E, Stone S, Omaira M
Front Oncol
. 2024 Dec;
14:1401208.
PMID: 39703838
Background: Richter's transformation (RT) in chronic lymphocytic leukemia (CLL) is associated with poor prognosis and requires prompt modifications in patient care. CLL patients are susceptible to severe infections due to...
2.
Skelsey M, Loftis B, Kaufmann M, Siegel D, Bhatia N, Wangia M, et al.
J Am Acad Dermatol
. 2024 Nov;
92(3):620-621.
PMID: 39549846
No abstract available.
3.
Kaur K, Ai R, Perry A, Riley B, Roberts E, Montano E, et al.
J Invest Dermatol
. 2024 Mar;
144(10):2187-2196.e13.
PMID: 38513819
Skin cancer risk is increased by exposure to ultraviolet radiation (UVR). Because UVR exposure accumulates over time and lighter skin is more susceptible to UVR, age and skin tone are...
4.
Zhang H, Haun R, Collin F, Cassol C, Napier J, Wilson J, et al.
Lab Invest
. 2023 Dec;
104(3):100304.
PMID: 38092179
Gene expression profiling from formalin-fixed paraffin-embedded (FFPE) renal allograft biopsies is a promising approach for feasibly providing a molecular diagnosis of rejection. However, large-scale studies evaluating the performance of models...
5.
Stone S, Thoms-Rodriguez C, Cameron J, Seah C, Stephenson-Clarke S, Melano R
Microbiol Spectr
. 2023 Jan;
:e0345922.
PMID: 36719202
We have investigated the prevalence of carbapenemase-producing uropathogens at the University Hospital of the West Indies, Jamaica. From 64 unique urine samples collected between January and March 2020, only 2...
6.
Trock B, Jing Y, Mabey B, Sangale Z, Lenz L, Haney N, et al.
J Urol
. 2022 Nov;
208(6):1192-1193.
PMID: 36349916
No abstract available.
7.
Trock B, Jing Y, Mabey B, Sangale Z, Lenz L, Haney N, et al.
J Urol
. 2022 Aug;
208(6):1182-1193.
PMID: 36006048
Purpose: The prognostic value for metastasis of the cell-cycle progression score and phosphatase and tensin homolog haven't been evaluated jointly in contemporary men with exclusively intermediate- or high-risk prostate cancer....
8.
Cheung R, Xu H, Jin X, Tian W, Pinney K, Bu L, et al.
Biomark Med
. 2022 Apr;
16(8):647-661.
PMID: 35485169
Allograft rejection remains a major cause of graft failure in kidney transplantation. Here the authors report the validation of a non-invasive molecular diagnostic assay, AlloMap Kidney, using peripheral blood. The...
9.
Tward J, Lenz L, Flake II D, Rajamani S, Yonover P, Olsson C, et al.
Int J Radiat Oncol Biol Phys
. 2021 Oct;
113(1):66-76.
PMID: 34610388
Purpose: The clinical cell-cycle risk (CCR) score, which combines the University of California, San Francisco's Cancer of the Prostate Risk Assessment (CAPRA) and the cell cycle progression (CCP) molecular score,...
10.
Cuzick J, Stone S, Lenz L, Flake D, Rajamani S, Moller H, et al.
Cancer Rep (Hoboken)
. 2021 Aug;
5(8):e1535.
PMID: 34423592
Background: Validation of biomarker-based prognostic models to improve risk stratification in men with localized prostate cancer (PrCa) remains a clinical need. It has previously been shown that the cell cycle...